If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 29 Similar Profiles
Type 2 Diabetes Mellitus Medicine & Life Sciences
Population Medicine & Life Sciences
Cardiovascular Diseases Medicine & Life Sciences
Independent Living Medicine & Life Sciences
Blood Pressure Medicine & Life Sciences
Stroke Medicine & Life Sciences
Glucose Medicine & Life Sciences
Cerebral Hemorrhage Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2019

Coffee drinking and risk of all-cause mortality and cardiovascular diseases

Hirakawa, Y., Apr 1 2019, In : Circulation Journal. 83, 4, p. 711-712 2 p.

Research output: Contribution to journalEditorial

Open Access
Coffee
Drinking
Cardiovascular Diseases
Mortality

Dairy consumption and risk of functional disability in an elderly Japanese population: The Hisayama Study

Yoshida, D., Ohara, T., Hata, J., Shibata, M., Hirakawa, Y., Honda, T., Uchida, K., Takasugi, S., Kitazono, T., Kiyohara, Y. & Ninomiya, T., Jun 1 2019, In : American Journal of Clinical Nutrition. 109, 6, p. 1664-1671 8 p.

Research output: Contribution to journalArticle

Activities of Daily Living
Population
Independent Living
Geriatrics
Mental Competency
3 Citations (Scopus)

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials

Blood Pressure Lowering Treatment Trialists’ Collaboration, Jan 1 2019, In : Journal of hypertension. 37, 1, p. 16-23 8 p.

Research output: Contribution to journalArticle

Blood Pressure
Coronary Disease
Stroke
Therapeutics
MEDLINE
2 Citations (Scopus)

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

ENCHANTED Investigators and Coordinators, Mar 2 2019, In : The Lancet. 393, 10174, p. 877-888 12 p.

Research output: Contribution to journalArticle

Stroke
Blood Pressure
Tissue Plasminogen Activator
Guidelines
Therapeutics
Exercise
Population
Independent Living
Japan
Light